View on Pubmed.gov 34766135 | View on doi.org 10.1002/mco2.27
Lipid metabolism in cancer progression and therapeutic strategies.
- Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute & Institutes of Biomedical Sciences Fudan University Shanghai China.
- Medical Clinic and Policlinic IV Ludwig-Maximilian-University (LMU) Munich Germany.
- General, Visceral and Cancer Surgery University Hospital of Cologne Cologne Germany.
- Department of General Surgery, Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China.
Abstract
Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent lipids that act as energy producers, signaling molecules, and source material for the biogenesis of cell membranes. The enhanced synthesis, storage, and uptake of lipids contribute to cancer progression. The rewiring of lipid metabolism in cancer has been linked to the activation of oncogenic signaling pathways and cross talk with the tumor microenvironment. The resulting activity favors the survival and proliferation of tumor cells in the harsh conditions within the tumor. Lipid metabolism also plays a vital role in tumor immunogenicity via effects on the function of the noncancer cells within the tumor microenvironment, especially immune-associated cells. Targeting altered lipid metabolism pathways has shown potential as a promising anticancer therapy. Here, we review recent evidence implicating the contribution of lipid metabolic reprogramming in cancer to cancer progression, and discuss the molecular mechanisms underlying lipid metabolism rewiring in cancer, and potential therapeutic strategies directed toward lipid metabolism in cancer. This review sheds new light to fully understanding of the role of lipid metabolic reprogramming in the context of cancer and provides valuable clues on therapeutic strategies targeting lipid metabolism in cancer.
References
Cancer Lett. 2017 Aug 10;401:39-45
Cell Metab. 2019 Apr 2;29(4):886-900.e5
Nat Med. 2016 Apr;22(4):427-32
Adv Biol Regul. 2016 Jan;60:151-159
Cited by 224 citations (total)
Journal Article Review
Lipid metabolism in cancer progression and therapeutic strategies.
Electronic publication date November 13, 2021
Yan Fu [...] Qiongzhu Dong et al.
Dysregulated lipid metabolism represents an important metabolic alteration in cancer. Fatty acids, cholesterol, and phospholipid are the three most prevalent...
Journal Article
Untargeted metabolomic and lipidomic analyses reveal lipid dysregulation in the plasma of acute leukemia patients.
Electronic publication date November 29, 2023
Cindy Arévalo [...] Susana Fiorentino et al.
Acute leukemias (AL) are aggressive neoplasms with high mortality rates. Metabolomics and oxidative status have emerged as important tools to...
Conflict of interest statement
MeSH
- •
- •
- •
Specialties
- •
- •
Copyright
© 2020 The Authors. MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.